Sagimet Biosciences Inc.(SGMT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SGMT Sagimet Biosciences Inc.

盘前交易 11-26 05:53:23 EST

4.93

+0.17

+3.57%

最高5.11	最低4.87	成交量37.34万
今开4.90	昨收4.76	日振幅5.04%
总市值1.59亿	流通市值8,111万	总股本3,220万
成交额187.45万	换手率2.27%	流通股本1,645万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SGMT","market":"US","secType":"STK","nameCN":"Sagimet Biosciences Inc.","latestPrice":4.93,"timestamp":1732568400000,"preClose":4.76,"halted":0,"volume":373406,"delay":0,"floatShares":16451460,"shares":32195345,"eps":-1.287523,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.17,"latestTime":"11-26 05:53:23 EST","open":4.9,"high":5.11,"low":4.87,"amount":1874479.0762940003,"amplitude":0.05042,"askPrice":6.51,"askSize":100,"bidPrice":4.5,"bidSize":600,"shortable":3,"etf":0,"ttmEps":-1.287523,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732631400000},"adr":0,"listingDate":1689307200000,"adjPreClose":4.93,"postHourTrading":{"tag":"盘后","latestPrice":4.93,"preClose":4.93,"latestTime":"18:56 EST","volume":646,"amount":3219.278,"timestamp":1732578998242},"volumeRatio":0.8250085037941041,"impliedVol":1.4936,"impliedVolPercentile":0.3386},"requestUrl":"/m/hq/s/SGMT/tweets","defaultTab":"tweets","newsList":[{"id":"2486358560","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘快速上涨5.25%报5.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486358560","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486358560?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:35","pubTimestamp":1732545311,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时35分，Sagimet Biosciences Inc. - Series A股票出现异动，股价快速上涨5.25%。截至发稿，该股报5.01美元/股，成交量2.4927万股，换手率0.08%，振幅2.31%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为1.10%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522351298e44673&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522351298e44673&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2485115362","title":"Sagimet Biosciences Inc. - Series A盘中异动 临近收盘急速上涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485115362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485115362?lang=zh_cn&edition=full","pubTime":"2024-11-23 04:52","pubTimestamp":1732308743,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日04时52分，Sagimet Biosciences Inc. - Series A股票出现波动，股价急速上涨5.11%。截至发稿，该股报4.73美元/股，成交量33.4984万股，换手率1.04%，振幅8.59%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.42%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123045223a24eb6c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123045223a24eb6c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2485244869","title":"Sagimet Biosciences Inc. - Series A盘中异动 大幅拉升5.31%报4.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485244869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485244869?lang=zh_cn&edition=full","pubTime":"2024-11-22 01:45","pubTimestamp":1732211146,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日01时45分，Sagimet Biosciences Inc. - Series A股票出现波动，股价大幅拉升5.31%。截至发稿，该股报4.76美元/股，成交量30.081万股，换手率0.93%，振幅10.40%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.51%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122014547971a7efb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122014547971a7efb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2484920707","title":"Sagimet Biosciences Inc. - Series A盘中异动 大幅上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484920707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484920707?lang=zh_cn&edition=full","pubTime":"2024-11-20 01:10","pubTimestamp":1732036253,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日01时10分，Sagimet Biosciences Inc. - Series A股票出现波动，股价快速拉升5.05%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体跌幅为0.91%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112001105398e438f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112001105398e438f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2484716116","title":"Sagimet Biosciences Inc. - Series A盘中异动 快速下挫6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484716116","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484716116?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:01","pubTimestamp":1731942093,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时01分，Sagimet Biosciences Inc. - Series A股票出现波动，股价大幅跳水6.13%。截至发稿，该股报4.44美元/股，成交量4.8446万股，换手率0.15%，振幅6.89%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体跌幅为0.62%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118230133971a7331&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118230133971a7331&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2483820428","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大涨6.48%报6.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483820428","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483820428?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:53","pubTimestamp":1731509596,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时53分，Sagimet Biosciences Inc. - Series A股票出现异动，股价快速拉升6.48%。截至发稿，该股报6.33美元/股，成交量8.4619万股，换手率0.26%，振幅6.40%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.39%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113225317971a64e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113225317971a64e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2482703756","title":"Sagimet Biosciences Inc. - Series A盘中异动 下午盘大幅下挫5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482703756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482703756?lang=zh_cn&edition=full","pubTime":"2024-11-12 02:23","pubTimestamp":1731349411,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日02时23分，Sagimet Biosciences Inc. - Series A股票出现波动，股价快速跳水5.56%。截至发稿，该股报5.61美元/股，成交量25.0754万股，换手率0.78%，振幅6.48%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体跌幅为0.70%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112022331abb6cd3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112022331abb6cd3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2481953593","title":"Sagimet Biosciences Inc. - Series A盘中异动 股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481953593","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481953593?lang=zh_cn&edition=full","pubTime":"2024-11-05 00:18","pubTimestamp":1730737096,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日00时18分，Sagimet Biosciences Inc. - Series A股票出现波动，股价急速上涨5.44%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.45%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105001816a2157887&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105001816a2157887&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2480889109","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘急速上涨5.76%报5.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480889109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480889109?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:34","pubTimestamp":1730468079,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时34分，Sagimet Biosciences Inc. - Series A股票出现异动，股价快速拉升5.76%。截至发稿，该股报5.45美元/股，成交量3.2136万股，换手率0.10%，振幅4.47%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.20%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121344198e3fff1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121344198e3fff1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2479730141","title":"Sagimet Biosciences Inc. - Series A盘中异动 下午盘股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479730141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479730141?lang=zh_cn&edition=full","pubTime":"2024-10-31 01:41","pubTimestamp":1730310080,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日01时41分，Sagimet Biosciences Inc. - Series A股票出现异动，股价大幅下挫5.23%。截至发稿，该股报5.53美元/股，成交量38.9514万股，换手率1.21%，振幅7.20%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体跌幅为0.25%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031014120a1fbf7a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031014120a1fbf7a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2478697489","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478697489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478697489?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:46","pubTimestamp":1730123169,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时46分，Sagimet Biosciences Inc. - Series A股票出现异动，股价快速拉升5.01%。截至发稿，该股报5.87美元/股，成交量4.8669万股，换手率0.15%，振幅3.58%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.57%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214609971a2a5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214609971a2a5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2478951280","title":"Sagimet Biosciences Inc. - Series A盘中异动 下午盘股价大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478951280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478951280?lang=zh_cn&edition=full","pubTime":"2024-10-26 01:18","pubTimestamp":1729876717,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日01时18分，Sagimet Biosciences Inc. - Series A股票出现异动，股价快速上涨5.27%。截至发稿，该股报5.79美元/股，成交量38.7606万股，换手率1.20%，振幅7.63%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.70%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026011837971a260e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026011837971a260e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":1},{"id":"2477556527","title":"Sagimet Biosciences Inc. - Series A盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477556527","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477556527?lang=zh_cn&edition=full","pubTime":"2024-10-24 00:30","pubTimestamp":1729701059,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日00时30分，Sagimet Biosciences Inc. - Series A股票出现异动，股价大幅下跌5.08%。截至发稿，该股报5.60美元/股，成交量40.0191万股，换手率1.24%，振幅7.71%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体跌幅为1.11%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024003059a1e4688a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024003059a1e4688a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2477966354","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大涨5.03%报5.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477966354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477966354?lang=zh_cn&edition=full","pubTime":"2024-10-22 23:27","pubTimestamp":1729610848,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日23时27分，Sagimet Biosciences Inc. - Series A股票出现异动，股价快速拉升5.03%。截至发稿，该股报5.85美元/股，成交量29.8009万股，换手率0.93%，振幅5.57%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体跌幅为0.39%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022232728a1e2d4cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022232728a1e2d4cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2477862562","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘急速上涨5.73%报5.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477862562","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477862562?lang=zh_cn&edition=full","pubTime":"2024-10-21 23:05","pubTimestamp":1729523141,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日23时05分，Sagimet Biosciences Inc. - Series A股票出现异动，股价急速拉升5.73%。截至发稿，该股报5.72美元/股，成交量44.6万股，换手率1.39%，振幅8.33%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体跌幅为0.30%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102123054198e3d911&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102123054198e3d911&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2476325510","title":"Sagimet Biosciences Inc. - Series A盘中异动 急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476325510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476325510?lang=zh_cn&edition=full","pubTime":"2024-10-18 21:54","pubTimestamp":1729259671,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日21时54分，Sagimet Biosciences Inc. - Series A股票出现异动，股价急速跳水5.00%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体跌幅为0.35%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101821543198e3d45f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101821543198e3d45f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2475339521","title":"Sagimet Biosciences Inc. - Series A盘中异动 大幅拉升5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475339521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475339521?lang=zh_cn&edition=full","pubTime":"2024-10-14 22:29","pubTimestamp":1728916175,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日22时29分，Sagimet Biosciences Inc. - Series A股票出现波动，股价急速拉升5.57%。截至发稿，该股报4.55美元/股，成交量15.9087万股，换手率0.49%，振幅5.32%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体跌幅为0.39%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014222935ab69feaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014222935ab69feaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2474092550","title":"Sagimet Biosciences Inc. - Series A盘中异动 快速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474092550","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474092550?lang=zh_cn&edition=full","pubTime":"2024-10-11 21:39","pubTimestamp":1728653999,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日21时39分，Sagimet Biosciences Inc. - Series A股票出现波动，股价大幅拉升5.07%。截至发稿，该股报4.35美元/股，成交量13.4642万股，换手率0.42%，振幅7.25%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.27%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011213959a1e002a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011213959a1e002a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2473110592","title":"Sagimet Biosciences Inc. - Series A盘中异动 大幅下挫5.04%报3.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473110592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473110592?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:45","pubTimestamp":1728308732,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时45分，Sagimet Biosciences Inc. - Series A股票出现波动，股价大幅下挫5.04%。截至发稿，该股报3.88美元/股，成交量18.1682万股，换手率0.56%，振幅5.62%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中，整体涨幅为0.09%。Sagimet Biosciences Inc. - Series A公司简介：Sagimet Biosciences Inc 是一家临床阶段的生物制药公司，专注于开发一系列内部发现的、选择性脂肪酸合酶  抑制剂，以治疗由脂质代谢途径功能失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072145329719ea3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072145329719ea3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2472957083","title":"Aeon Biopharma, Inc.盘中异动 快速拉升8.06%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472957083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472957083?lang=zh_cn&edition=full","pubTime":"2024-10-04 21:45","pubTimestamp":1728049553,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日21时45分，Aeon Biopharma, Inc.股票出现异动，股价快速拉升8.06%。截至发稿，该股报1.20美元/股，成交量5291股，换手率0.01%，振幅2.25%。Aeon Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Aeon Biopharma, Inc.公司简介：AEON Biopharma Inc 是一家临床阶段的生物制药公司，专注于开发其专有的肉毒杆菌毒素复合物 ABP-450注射剂，用于衰弱的医疗状况，最初的重点是神经科学市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100421455398e3a994&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100421455398e3a994&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139","AEON"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sagimet.com","stockEarnings":[{"period":"1week","weight":0.1307},{"period":"1month","weight":-0.1181},{"period":"3month","weight":0.6217},{"period":"6month","weight":-0.0987},{"period":"1year","weight":0.2024},{"period":"ytd","weight":-0.0904}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sagimet Biosciences Inc.于2006年12月19日在特拉华州注册成立，名称为3-V Biosciences，Inc.，总部位于加利福尼亚州圣马特奥。该公司于2019年8月将其名称从3-V Biosciences，Inc.更改为Sagimet Biosciences Inc.。该公司是临床阶段的生物制药公司，致力于开发内部发现的选择性脂肪酸合酶抑制剂组合，用于治疗因脂质代谢功能障碍而导致的疾病。","exchange":"NASDAQ","name":"Sagimet Biosciences Inc.","nameEN":"Sagimet Biosciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sagimet Biosciences Inc.(SGMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sagimet Biosciences Inc.(SGMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sagimet Biosciences Inc.,SGMT,Sagimet Biosciences Inc.股票,Sagimet Biosciences Inc.股票老虎,Sagimet Biosciences Inc.股票老虎国际,Sagimet Biosciences Inc.行情,Sagimet Biosciences Inc.股票行情,Sagimet Biosciences Inc.股价,Sagimet Biosciences Inc.股市,Sagimet Biosciences Inc.股票价格,Sagimet Biosciences Inc.股票交易,Sagimet Biosciences Inc.股票购买,Sagimet Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sagimet Biosciences Inc.(SGMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sagimet Biosciences Inc.(SGMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}